BioPharma Services, Scentryphar partner

Wednesday, February 11, 2015

BioPharma Services (BPSI) has entered into a partnership and joint venture agreement with Scentryphar, a CRO located in Sao Paulo, Brazil. The partnership will support local and global sponsors looking to bring generic and innovative drugs to the Brazilian market by offering one-stop shopping and joint experience in clinical conduct, bioanalysis, data management, statistics and scientific and medical writing.

BioPharma Services is a physician-owned, physician-run, FDA-inspected, U.K. MHRA-inspected and Health Canada-inspected international CRO. It is privately held and is headquartered in Toronto.

“We are extremely pleased to partner with Scentryphar to offer generic and phases I-IV project management for Brazilian submission. This strategic alliance will allow our sponsors to bring products in Brazil in a timely fashion while maintaining high quality standards,” said Renzo DiCarlo, CEO at BPSI.

Looking for more news, check out the new FREE CenterWatch Weekly!

The new FREE CenterWatch Weekly is your source of critical news, emerging trends, and business issues around everything in the rapidly changing clinical research marketplace. Check out our new CWWeekly page! Sign up today for your free email newsletter, update your bookmarks and check us out regularly! We look forward to bringing you the best news and information about clinical research in 2018!